» Articles » PMID: 14997295

EPISEPSIS: a Reappraisal of the Epidemiology and Outcome of Severe Sepsis in French Intensive Care Units

Overview
Specialty Critical Care
Date 2004 Mar 5
PMID 14997295
Citations 206
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Ten years ago 8.4% of patients in French intensive care units (ICUs) were found to have severe sepsis or shock and 56% died in the hospital. As novel therapies for severe sepsis are emerging, updated epidemiological information is required.

Design And Setting: An inception cohort study conducted in 206 ICUs of randomly selected hospitals over a 2-week period in 2001, including all patients meeting criteria for clinically or microbiologically documented severe sepsis (with > or =1 organ dysfunction).

Measurements And Results: Among 3738 admissions, 546 (14.6%) patients experienced severe sepsis or shock, of which 30% were ICU-acquired. The median age of patients was 65 years, and 54.1% had at least one chronic organ system dysfunction. The median (range) Simplified Acute Physiology Score (SAPS II) and Sequential Organ Failure Assessment (SOFA) at onset of severe sepsis were 48 (2-129) and 9 (1-24), respectively. Mortality was 35% at 30 days; at 2 months the mortality rate was 41.9%, and 11.4% of patients remained hospitalized. The median (range) hospital stay was 25 (0-112) days in survivors and 7 (0-90) days in non-survivors. Chronic liver and heart failure, acute renal failure and shock, SAPS II at onset of severe sepsis and 24-h total SOFA scores were the independent risk factors most strongly associated with death.

Conclusions: Although the attack rate of severe sepsis in French ICUs appears to have increased over the past decade, its associated mortality has decreased, suggesting improved management of patients. Severe sepsis incurs considerable resources use, and implementation of effective management strategies and continued research efforts are needed.

Citing Articles

Rapid molecular assays versus blood culture for bloodstream infections: a systematic review and meta-analysis.

Rapszky G, Do To U, Kiss V, Koi T, Walter A, Gergo D EClinicalMedicine. 2025; 79:103028.

PMID: 39968206 PMC: 11833021. DOI: 10.1016/j.eclinm.2024.103028.


Comparative Analysis of Bacteremic and Non-bacteremic Sepsis: A Retrospective Study.

Lee R, Al Rifaie R, Subedi K, Coletti C Cureus. 2025; 16(12):e76418.

PMID: 39872553 PMC: 11770239. DOI: 10.7759/cureus.76418.


Ferrostatin-1 improves acute sepsis-induced cardiomyopathy via inhibiting neutrophil infiltration through impaired chemokine axis.

Li J, Xiao F, Lin B, Huang Z, Wu M, Ma H Front Cell Dev Biol. 2024; 12:1510232.

PMID: 39726718 PMC: 11669711. DOI: 10.3389/fcell.2024.1510232.


Septic shock in the immunocompromised cancer patient: a narrative review.

Nates J, Pene F, Darmon M, Mokart D, Castro P, David S Crit Care. 2024; 28(1):285.

PMID: 39215292 PMC: 11363658. DOI: 10.1186/s13054-024-05073-0.


Subphenotypes of platelet count trajectories in sepsis from multi-center ICU data.

Wang K, Lu D, Wang F Sci Rep. 2024; 14(1):20187.

PMID: 39215039 PMC: 11364765. DOI: 10.1038/s41598-024-71186-9.


References
1.
Annane D, Sebille V, Charpentier C, Bollaert P, Francois B, Korach J . Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002; 288(7):862-71. DOI: 10.1001/jama.288.7.862. View

2.
Knaus W, Sun X, Nystrom O, Wagner D . Evaluation of definitions for sepsis. Chest. 1992; 101(6):1656-62. DOI: 10.1378/chest.101.6.1656. View

3.
Wesley Ely E, Laterre P, Angus D, Helterbrand J, Levy H, Dhainaut J . Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med. 2003; 31(1):12-9. DOI: 10.1097/00003246-200301000-00002. View

4.
Cohen J, Guyatt G, Bernard G, Calandra T, Cook D, Elbourne D . New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med. 2001; 29(4):880-6. DOI: 10.1097/00003246-200104000-00039. View

5.
Levy M, Fink M, Marshall J, Abraham E, Angus D, Cook D . 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31(4):1250-6. DOI: 10.1097/01.CCM.0000050454.01978.3B. View